Nvidia’s forthright ambitions to expand its drug development footprint ... What programming languages like R and Python are to data ... Recursion's work has also drawn in partnerships with ...

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI ...